Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Pancreas ; 44(7): 1111-20, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26333110

ABSTRACT

OBJECTIVES: In injury conditions, myofibroblasts are induced to lay down matrix proteins and support the repair process. In this study, we investigated the role of myofibroblasts, particularly stellate cells, in the growth and regeneration of pancreatic ß cells. METHODS: We used both in vitro and in vivo approaches to address whether stellate cells may promote the growth of ß cells. RESULTS: Our experiments demonstrated that activated stellate cells support the proliferation of ß cells in vitro. In vivo, mesenchymals surrounding the pancreatic islets are activated (induced to proliferate) in the islet regeneration model of Pten null mice. These mesenchymals display markers of pancreatic stellate cells, such as desmin and to a lesser extent, smooth muscle actin α. We have shown previously that targeted ß-cell deletion of Pten lead to a significant increase in total islet mass. This phenotype was accompanied by an increase in peri-islet mitotic activity, particularly in islets injured by streptozotocin, a ß cell-specific toxin. CONCLUSIONS: Together with the in vitro observations, our data, here, suggest that that these mesenchymal cells may support the regeneration of the islets. Identifying how the communication occurs may provide clinically relevant mechanism for inducing ß-cell regeneration.


Subject(s)
Insulin-Secreting Cells/physiology , Myofibroblasts/physiology , Pancreas/physiopathology , Pancreatic Stellate Cells/physiology , Actins/metabolism , Animals , Cell Communication/physiology , Cell Line, Tumor , Cell Proliferation , Cells, Cultured , Coculture Techniques , Desmin/metabolism , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Immunohistochemistry , Insulin-Secreting Cells/cytology , Male , Mesenchymal Stem Cells/chemistry , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/physiology , Mice, Knockout , Mice, Transgenic , Myofibroblasts/cytology , PTEN Phosphohydrolase/deficiency , PTEN Phosphohydrolase/genetics , Pancreas/injuries , Pancreas/metabolism , Pancreatic Stellate Cells/chemistry , Pancreatic Stellate Cells/cytology , Rats , Regeneration/physiology
2.
Diabetologia ; 57(2): 352-61, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24162585

ABSTRACT

AIMS/HYPOTHESIS: Adult beta cells have a diminished ability to proliferate. Phosphatase and tensin homologue (PTEN) is a lipid phosphatase that antagonises the function of the mitogenic phosphatidylinositol 3-kinase (PI3K) pathway. The objective of this study was to understand the role of PTEN and PI3K signalling in the maintenance of beta cells postnatally. METHODS: We developed a Pten (lox/lox); Rosa26 (lacZ); RIP-CreER (+) model that permitted us to induce Pten deletion by treatment with tamoxifen in mature animals. We evaluated islet mass and function as well as beta cell proliferation in 3- and 12-month-old mice treated with tamoxifen (Pten deleted) vs mice treated with vehicle (Pten control). RESULTS: Deletion of Pten in juvenile (3-month-old) beta cells significantly induced their proliferation and increased islet mass. The expansion of islet mass occurred concomitantly with the enhanced ability of the Pten-deleted mice to maintain euglycaemia in response to streptozotocin treatment. In older mice (>12 months of age), deletion of Pten similarly increased islet mass and beta cell proliferation. This novel finding suggests that PTEN-regulated mechanisms may override the age-onset diminished ability of beta cells to respond to mitogenic stimulation. We also found that proteins regulating G1/S cell-cycle transition, such as cyclin D1, cyclin D2, p27 and p16, were altered when PTEN was lost, suggesting that they may play a role in PTEN/PI3K-regulated beta cell proliferation in adult tissue. CONCLUSIONS/INTERPRETATION: The signals regulated by the PTEN/PI3K pathway are important for postnatal maintenance of beta cells and regulation of their proliferation in adult tissues.


Subject(s)
Aging/pathology , Diabetes Mellitus, Experimental/pathology , Insulin-Secreting Cells/metabolism , PTEN Phosphohydrolase/metabolism , Animals , Cell Cycle , Cell Death , Cell Proliferation , DNA Methylation , Diabetes Mellitus, Experimental/metabolism , Down-Regulation/genetics , Gene Deletion , Homeostasis , Male , Mice , Mice, Mutant Strains , PTEN Phosphohydrolase/deficiency , Signal Transduction , Up-Regulation
3.
Aging Cell ; 12(6): 1000-11, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23826727

ABSTRACT

Tissue regeneration diminishes with age, concurrent with declining hormone levels including growth factors such as insulin-like growth factor-1 (IGF-1). We investigated the molecular basis for such decline in pancreatic ß-cells where loss of proliferation occurs early in age and is proposed to contribute to the pathogenesis of diabetes. We studied the regeneration capacity of ß-cells in mouse model where PI3K/AKT pathway downstream of insulin/IGF-1 signaling is upregulated by genetic deletion of Pten (phosphatase and tensin homologue deleted on chromosome 10) specifically in insulin-producing cells. In this model, PTEN loss prevents the decline in proliferation capacity in aged ß-cells and restores the ability of aged ß-cells to respond to injury-induced regeneration. Using several animal and cell models where we can manipulate PTEN expression, we found that PTEN blocks cell cycle re-entry through a novel pathway leading to an increase in p16(ink4a), a cell cycle inhibitor characterized for its role in cellular senescence/aging. A downregulation in p16(ink4a) occurs when PTEN is lost as a result of cyclin D1 induction and the activation of E2F transcription factors. The activation of E2F transcriptional factors leads to methylation of p16(ink4a) promoter, an event that is mediated by the upregulation of polycomb protein, Ezh2. These analyses establish a novel PTEN/cyclin D1/E2F/Ezh2/p16(ink4a) signaling network responsible for the aging process and provide specific evidence for a molecular paradigm that explain how decline in growth factor signals such as IGF-1 (through PTEN/PI3K signaling) may control regeneration and the lack thereof in aging cells.


Subject(s)
Cell Cycle , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/pathology , PTEN Phosphohydrolase/metabolism , Aging/pathology , Animals , Cell Proliferation , Cyclin D1/metabolism , Cyclin-Dependent Kinase Inhibitor p27/metabolism , DNA Methylation/genetics , Down-Regulation/genetics , Enhancer of Zeste Homolog 2 Protein , Gene Deletion , Humans , Mice , PTEN Phosphohydrolase/deficiency , Polycomb Repressive Complex 2/genetics , Polycomb Repressive Complex 2/metabolism , Signal Transduction , Up-Regulation/genetics
4.
Gastroenterology ; 139(6): 2170-82, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20837017

ABSTRACT

BACKGROUND & AIMS: The tumor suppressor PTEN inhibits AKT2 signaling; both are aberrantly expressed in liver tumors. We investigated how PTEN and AKT2 regulate liver carcinogenesis. Loss of PTEN leads to spontaneous development of liver tumors from progenitor cells. We investigated how the loss of PTEN activates liver progenitor cells and induces tumorigenesis. METHODS: We studied mice with liver-specific disruptions in Pten and the combination of Pten and Akt2 to investigate mechanisms of liver carcinogenesis. RESULTS: PTEN loss leads to hepatic injury and establishes selective pressure for tumor-initiating cells (TICs), which proliferate to form mixed-lineage tumors. The Pten-null mice had increasing levels of hepatic injury before proliferation of hepatic progenitors. Attenuation of hepatic injury by deletion of Akt2 reduced progenitor cell proliferation and delayed tumor development. In Pten/Akt2-null mice given 3,5-diethoxycarbonyl-1,4 dihydrocollidine (DDC), we found that the primary effect of AKT2 loss was attenuation of hepatic injury and not inhibition of progenitor-cell proliferation in response to injury. CONCLUSIONS: Liver carcinogenesis in Pten-null mice requires not only the transformation of TICs but selection pressure from hepatic injury and cell death, which activates TICs. Further research is required to elucidate the mechanism for hepatic injury and its relationship with TIC activation.


Subject(s)
Chemical and Drug Induced Liver Injury , Liver Neoplasms , PTEN Phosphohydrolase/genetics , PTEN Phosphohydrolase/metabolism , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Animals , Cell Line , Cell Survival/physiology , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Chemical and Drug Induced Liver Injury/genetics , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Gene Expression Regulation, Neoplastic/physiology , Intercellular Signaling Peptides and Proteins/metabolism , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Pyridines/toxicity , Signal Transduction/physiology , Stem Cells/pathology
5.
Open Endocrinol J ; 4: 23-32, 2010.
Article in English | MEDLINE | ID: mdl-23853672

ABSTRACT

This paper describes the biological functions of PTEN and the PTEN regulated signaling pathway in pancreatic ß-cells. PTEN has been shown to regulate the regeneration of ß-cells. We review the pathways that are controlled by PTEN signaling and their functions in ß-cell regeneration. In particular, we describe the unique effect of Pten deletion in ß-cells. Unlike its effect in other tissues, Pten deletion does not lead to tumor formation but does enhance ß-cell proliferation and function. In addition to the literature review, we also report new results exploring PTEN loss in adult ß-cells. We demonstrate that inducing PTEN loss in adult cells has the same regenerative effects previously found for prenatal deletion.

6.
Brain Res ; 1230: 290-302, 2008 Sep 16.
Article in English | MEDLINE | ID: mdl-18674521

ABSTRACT

The blood-brain tumor barrier (BTB) significantly limits delivery of therapeutic concentrations of chemotherapy to brain tumors. A novel approach to selectively increase drug delivery is pharmacologic modulation of signaling molecules that regulate BTB permeability, such as those in cGMP signaling. Here we show that oral administration of sildenafil (Viagra) and vardenafil (Levitra), inhibitors of cGMP-specific PDE5, selectively increased tumor capillary permeability in 9L gliosarcoma-bearing rats with no significant increase in normal brain capillaries. Tumor-bearing rats treated with the chemotherapy agent, adriamycin, in combination with vardenafil survived significantly longer than rats treated with adriamycin alone. The selective increase in tumor capillary permeability appears to be mediated by a selective increase in tumor cGMP levels and increased vesicular transport through tumor capillaries, and could be attenuated by iberiotoxin, a selective inhibitor for calcium-dependent potassium (K(Ca)) channels, that are effectors in cGMP signaling. The effect by sildenafil could be further increased by simultaneously using another BTB "opener", bradykinin. Collectively, this data demonstrates that oral administration of PDE5 inhibitors selectively increases BTB permeability and enhances anti-tumor efficacy for a chemotherapeutic agent. These findings have significant implications for improving delivery of anti-tumor agents to brain tumors.


Subject(s)
Antineoplastic Agents/therapeutic use , Brain Neoplasms/drug therapy , Brain Neoplasms/metabolism , Glioma/drug therapy , Glioma/metabolism , Phosphodiesterase 5 Inhibitors , Phosphodiesterase Inhibitors/pharmacology , Animals , Autoradiography , Blood Pressure/drug effects , Brain Chemistry/drug effects , Brain Neoplasms/pathology , Capillaries/pathology , Capillary Permeability/drug effects , Cyclic GMP/blood , Cyclic GMP/metabolism , Female , Glioma/pathology , Imidazoles/pharmacology , Microscopy, Electron, Transmission , Neovascularization, Pathologic/pathology , Piperazines/pharmacology , Purines/pharmacology , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction , Sildenafil Citrate , Sucrose/metabolism , Sulfones/pharmacology , Survival Analysis , Tight Junctions/drug effects , Tight Junctions/ultrastructure , Triazines/pharmacology , Vardenafil Dihydrochloride
7.
Brain Res ; 1227: 198-206, 2008 Aug 28.
Article in English | MEDLINE | ID: mdl-18602898

ABSTRACT

The blood-brain tumor barrier (BTB) significantly limits delivery of effective concentrations of chemotherapeutic drugs to brain tumors. Previous studies suggest that BTB permeability may be modulated via alteration in the activity of potassium channels. In this study, we studied the relationship of BTB permeability increase mediated by potassium channel agonists to channel expression in two rat brain tumor models. Intravenous infusion of KCO912 (K(ATP) agonist), minoxidil sulfate (K(ATP) agonist) or NS1619 (K(Ca) agonist) increased tumor permeability more in the 9L allogeneic brain tumor model than in the syngeneic brain tumor model. Consistently, expression of both K(ATP) and K(Ca) channels in 9L tumors was increased to a significantly greater extent in Wistar rats (allogeneic) as compared to Fischer rats (syngeneic). Furthermore, as a preliminary effort to understand clinical implication of potassium channels in brain tumor treatment, we determined the expression of K(ATP) in surgical specimens. K(ATP) mRNA was detected in glioblastoma multiforme (GBM) from nineteen patients examined, with a wide range of expression levels. Interestingly, in paired GBM tissues from seven patients before and after vaccination therapy, increased levels of K(ATP) were detected in five patients after vaccination that had positive response to chemotherapy after vaccination. The present study indicates that the effects of potassium channel agonists on BTB permeability are different between syngeneic and allogeneic models which have different expression levels of potassium channels. The expression of potassium channels in brain tumors is variable, which may be associated with different tumor permeability to therapeutic agents among patients.


Subject(s)
Brain Neoplasms/physiopathology , Capillary Permeability/drug effects , KATP Channels/agonists , Potassium Channels, Calcium-Activated/agonists , Animals , Benzimidazoles/administration & dosage , Benzimidazoles/therapeutic use , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/physiopathology , Blotting, Western , Brain Neoplasms/pathology , Brain Neoplasms/therapy , Cell Line, Tumor , Female , Glioblastoma/pathology , Glioblastoma/physiopathology , Glioblastoma/therapy , Humans , Immunohistochemistry , Injections, Intravenous , KATP Channels/genetics , KATP Channels/physiology , Microscopy, Confocal , Minoxidil/administration & dosage , Minoxidil/analogs & derivatives , Minoxidil/therapeutic use , Neoplasm Transplantation , Neoplasms, Experimental/pathology , Neoplasms, Experimental/physiopathology , Neoplasms, Experimental/therapy , Potassium Channels, Calcium-Activated/genetics , Potassium Channels, Calcium-Activated/physiology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred F344 , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Species Specificity , Vaccination/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...